Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell ...
The newly granted U.S. patent, No. 12,492,178, includes claims to the drug substance of EMP-01, and is expected to provide exclusivity through 2043. This patent identifies a highly-crystalline, ...
TipRanks on MSN
Atai Beckley granted US patent for EMP-01
Atai Beckley (ATAI) announced that the United States Patent and Trademark Office has granted a new patent covering EMP-01, further strengthening ...
Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback